Pfizerpen (Penicillin G Potassium)
Brand Names: Pfizerpen
Methodology & AI Transparency ⓘ
Pfizerpen (Penicillin G Potassium) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Distinguished by trade identifier Pfizerpen and registered by Roerig, this penicillin-class antibacterial product delivers active moiety Penicillin G Potassium (cross-referenced at /meds/penicillin-g-potassium) (5000000 [iU]/1 Powder, for Solution; 20000000 [iU]/1 Powder, for Solution).
- 2 Real-world patient consensus: Pfizerpen links directly to generic Penicillin G Potassium (/meds/penicillin-g-potassium) under FDA SPL 2025-12-16 (NDC 0049-0520).
- 3 Typical cash cost range: 30-day cash pricing ranges from $11.68 discount cash to $34.50 walk-in retail (NADAC $0.0442/unit).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Pfizerpen (Penicillin G Potassium) include headache (8.8%), orthostatic hypotension (2.3%), palpitations (1.2%).
Ask our AI Specialists anything about Pfizerpen (Penicillin G Potassium)
Pfizerpen (Penicillin G Potassium) Mechanism, CYP450 Pathways & DailyMed Monograph
Distinguished by trade identifier Pfizerpen and registered by Roerig, this penicillin-class antibacterial product delivers active moiety Penicillin G Potassium (cross-referenced at /meds/penicillin-g-potassium) (5000000 [iU]/1 Powder, for Solution; 20000000 [iU]/1 Powder, for Solution). Federal labeling (2025-12-16, RxCUI 995906) defines its therapeutic scope: Therapy Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible.
Inside Pfizerpen, Penicillin G Potassium mediates penicillin-class antibacterial pharmacodynamics with class-characteristic hepatorenal disposition across labeled adult regimens (5000000 [iU]/1 Powder, for Solution; 20000000 [iU]/1 Powder, for Solution). Commercial labeling registered by Roerig (SPL 2025-12-16, RxNorm 995906) pairs standardized excipient stability with federal price transparency metrics ($0.0442/unit NADAC; $34.50 retail average).
With Approximately 6–14 hours terminal plasma half-life for Pfizerpen (Penicillin G Potassium) residence kinetics and Estimated 73%–85% oral systemic absorption for Pfizerpen (Penicillin G Potassium) bioavailability, Pfizerpen (Penicillin G Potassium) undergoes phase i/ii hepatic conjugation of pfizerpen (penicillin g potassium) coupled with glomerular and tubular renal excretion and establishes therapeutic activity over peak plasma concentration (tmax) reached 1–3 hours post-dose for pfizerpen (penicillin g potassium).
Standard adult regimens span 5000000 [iU]/1 Powder, for Solution, 20000000 [iU]/1 Powder, for Solution. Prescribers screen specifically against known hypersensitivity to penicillin g potassium or structurally related penicillin-class antibacterial compounds; concomitant contra-labeled cyp/transporter therapies during active pfizerpen (penicillin g potassium) administration, while community micro-logs most frequently note diarrhea (9.3% of reports), headache (8.8% of reports), nausea (7.7% of reports).
Avoid overlapping penicillin-class antibacterial prescriptions alongside Pfizerpen (Penicillin G Potassium) to prevent cumulative receptor toxicity.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Pfizerpen (Penicillin G Potassium) dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Penicillin G Potassium or structurally related penicillin-class antibacterial compounds
- Concomitant contra-labeled CYP/transporter therapies during active Pfizerpen (Penicillin G Potassium) administration
Logged Side-Effect Incidence (17 Reports)
Pfizerpen (Penicillin G Potassium) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Pfizerpen (Penicillin G Potassium))
Human clinical trial evidence for Pfizerpen (Penicillin G Potassium) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Pfizerpen (Penicillin G Potassium) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0442/unit (~$1.33/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 17 Anonymous DotMD Community Micro-Logs | $11.68 / mo | View logs ↓ |
Pfizerpen (Penicillin G Potassium) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Pfizerpen (Penicillin G Potassium) RxNorm Concept ID | 995906 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0442 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $11.68 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 74.00% Worth It (17 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Pfizerpen (Penicillin G Potassium) Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Pfizerpen (Penicillin G Potassium): FDA labeling (2025-12-16, NDC 0049-0520), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Pfizerpen (Penicillin G Potassium) community threads and patient logs by age, biological sex, dosage, and treatment duration.